OMX Stockholm PI
1.020,74
PKT
-6,54
PKT
-0,64
%
Werbung
Analysen zu OMX Stockholm PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.09.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.09.23 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 18.09.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 18.09.23 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 18.09.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 15.09.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 15.09.23 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 15.09.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 15.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.09.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 15.09.23 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 13.09.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 12.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 11.09.23 | AstraZeneca Overweight | Barclays Capital | |
| 11.09.23 | AstraZeneca Buy | UBS AG | |
| 11.09.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.09.23 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 06.09.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 06.09.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 05.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 05.09.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.09.23 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 29.08.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 29.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.08.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 21.08.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 18.08.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 15.08.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.08.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 14.08.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 09.08.23 | Volvo (B) Sell | UBS AG | |
| 08.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.08.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 03.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.07.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 28.07.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.07.23 | ABB (Asea Brown Boveri) Neutral | Credit Suisse Group | |
| 25.07.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.07.23 | Nokia Buy | Deutsche Bank AG | |
| 24.07.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG |